Clinical trials: Behavioural Disorder
Attention Deficit Disorder With Hyperactivity
Group-based Cognitive-behavioral Therapy for Adults With Attention-deficit/Hyperactivity Disorder Inattentive-type
The newly developed CBT for ADHD inattentive-type (ADHD-I) protocol is tested for feasibility and acceptability in a pilot study with a single group design.
- Trial name
- NCT02889354
- Testing
- Cognitive-behavioral therapy
- Where
- Sweden
- Volunteers
- 40 people
- Sponsor
- Karolinska Institutet
Conduct Disorder, Attention Deficit Hyperactivity Disorder
Supplements and Social Skills Intervention Study
This is a 36-week, randomised, double-blind, placebo-controlled trial. The overarching aim of this study is to assess whether a nutritional intervention (Omega-3 supplement), when combined with a more traditional treatment…
- Conditions
- Conduct Disorder, Attention Deficit Hyperactivity Disorder, Oppositional Defiant Disorder
- Trial name
- SASSI (NCT00819429)
- Testing
- Omega-3, Social Skills Training, Standard Treatment (or TAU in Child Guidance Clinic)
- Where
- Singapore
- Volunteers
- 282 people
- Sponsor
- National Healthcare Group, Singapore
ADHD, Attention Deficit Hyperactivity Disorder
Brain Plasticity Underlying Acquisition of New Organizational Skills in Children
Organizational, time management and planning (OTMP) skills deficits are impairing features of developmental disorders, such as Attention Deficit Hyperactive Disorder (ADHD), which compromise school performance and family…
- Conditions
- ADHD, Attention Deficit Hyperactivity Disorder, Neurodevelopmental Disorders
- Trial name
- NCT04108273
- Testing
- Organizational Skills Training
- Where
- United States
- Volunteers
- 59 people
- Sponsor
- NYU Langone Health
Impulsive Aggression Comorbid With ADHD
Phase I Study to Assess the Absorption, Metabolism, and Excretion of [14C] Labeled SPN-810M
An Open-Label, Single-Dose, Mass-Balance Study to Assess the Absorption, Metabolism, and Excretion of Radio Labeled SPN-810M in Healthy Adult Male Volunteers
- Trial name
- NCT02023606
- Testing
- SPN-810M
- Where
- United Kingdom
- Volunteers
- 7 people, healthy volunteers welcome
- Sponsor
- Supernus Pharmaceuticals, Inc.
Pain in Elderly Patients Having Communication Disorders.
Concordance of Pain Detection in Patients by Doloplus® and Algoplus® Behavioural Scales
The pain of the elderly is often trivialized and ignored in spite of its high frequency: the chronic pain affects 50 % of the elderly living at home, 49 to 83 % of those living in institution and 80 % of this population at the…
- Trial name
- CALDOL (NCT02174744)
- Testing
- numeric pain rating scale
- Where
- France
- Volunteers
- 210 people
- Sponsor
- University Hospital, Clermont-Ferrand
Attention Deficit Hyperactivity Disorder
Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
There has been an increased interest in the association between ADHD and sleep disorders over the past years. A high incidence of sleep disturbance, ranging from 10% to 70%, has been identified in ADHD children regardless of…
- Trial name
- Zolkids (NCT00318448)
- Testing
- Zolpidem (SL800750)
- Where
- 2 sites in United States, Canada
- Volunteers
- 201 people
- Sponsor
- Sanofi
Attention Deficit Hyperactivity Disorder
Evaluation of the Effect of rTMS on Attention in Adults Diagnosed With Attention-Deficit Hyperactivity Disorder (ADHD)
The aim of the study is to evaluate the immediate effect of rTMS on attention in adults diagnosed with ADHD. the design is a double blind sham controlled crossover study.
- Trial name
- NCT00825708
- Testing
- rTMS
- Where
- Israel
- Volunteers
- 20 people
- Sponsor
- Shalvata Mental Health Center
Attention Deficit Hyperactivity Disorder
A Bioequivalence (BE) Study in Healthy Subjects
To demonstrate the bioequivalence of 12.5 milliliters (mL) of atomoxetine oral solution (4 milligrams per milliliter [mg/mL]) compared with 2 capsules of atomoxetine (25 mg per capsule) in healthy adult male Japanese subjects.
- Trial name
- NCT01177943
- Testing
- Atomoxetine
- Where
- Japan
- Volunteers
- 42 people, healthy volunteers welcome
- Sponsor
- Eli Lilly and Company
Disruptive Behavior Disorder, Childhood Onset, Attention Deficit Hyperactivity Disorder
Enhanced Support for Behavioral Barriers to Learning: An Evaluation of the SCHOOL STARS Program
This small pilot study will enroll children ages 5-12 years of age with disruptive behavior problems at school. These children and their families will be offered an enhanced model of primary care, which includes pre-visit record…
- Conditions
- Disruptive Behavior Disorder, Childhood Onset, Attention Deficit Hyperactivity Disorder, Oppositional Defiant Disorder in Children, Disruptive Mood Dysregulation Disorder
- Trial name
- NCT03669289
- Testing
- enhanced model of primary care
- Where
- United States
- Volunteers
- 14 people
- Sponsor
- Children's Hospital Medical Center, Cincinnati
Attention Deficit With Hyperactivity Disorder
Thyroid Profile in Attention Deficit With Hyperactivity Disorder (ADHD)
Rationale: The observational data of University Children's Hospitals of Nice, suggest that about a quarter of children and adolescents with ADHD may present with an abnormal thyroid profile.
- Trial name
- THYRADHD (NCT05080491)
- Testing
- immuno analysis and neuropsychological tests
- Where
- France
- Volunteers
- 400 people
- Sponsor
- Fondation Lenval
Generalized Anxiety Disorder
Testing Beliefs About Uncertainty in the Treatment of Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD) is an anxiety disorder characterized by excessive and uncontrollable worry. Our research group has developed a cognitive-behavioural treatment (CBT) for GAD centered upon intolerance of…
- Trial name
- NCT01958788
- Testing
- Cognitive-Behavioural Treatment
- Where
- Canada
- Volunteers
- 7 people
- Sponsor
- Concordia University, Montreal
Occupational Stress
Stress in Working Life
The goal of this realist evaluation of a Danish Cognitive Behavioral Therapy (CBT)-based stress management for patients with work-related stress is to understand what works, for whom, in what circumstances.The main objectives…
- Trial name
- NCT05791461
- Testing
- MARS (Measures Against Work-related Stress)
- Where
- Denmark
- Volunteers
- 500 people
- Sponsor
- University of Southern Denmark
Attention Deficit Hyperactivity Disorder
Pilot Feasibility Study of Neurofeedback for Attention Deficit Hyperactivity Disorder (ADHD)
Neurofeedback is increasingly advocated for treatment of ADHD despite a thin evidence base. The numerous open and partially controlled studies suffer serious design flaws.
- Trial name
- NCT00886483
- Testing
- Active Neurofeedback
- Where
- United States
- Volunteers
- 39 people
- Sponsor
- L. Eugene Arnold
Attention Deficit Hyperactivity Disorder, Attention Deficit Disorders With Hyperactivity
A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (process by which JNJ-31001074 is absorbed, distributed, metabolized, and eliminated by the body) after a single dose of JNJ-31001074.
- Trial name
- NCT00890240
- Testing
- JNJ-31001074
- Volunteers
- 18 people
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Oppositional Defiant Disorder
Treatment of Children With Peer Related Aggressive Behavior (ScouT)
The efficacy of the computer based Treatment Program for Children with Aggressive Behaviour (Soziales computerunterstütztes Training für Kinder mit aggressivem Verhalten, ScouT) which is a child focused social competence training…
- Trial name
- NCT02143427
- Testing
- Social Skills Training, Treatment Program with techniques to activate resources
- Where
- Germany
- Volunteers
- 140 people
- Sponsor
- University of Cologne
Attention Deficit/Hyperactivity Disorder
A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medications in Children With ADHD
This study will assess the efficacy of the text messaging (SMS-based) disease management intervention for children with Attention Deficit/Hyperactivity Disorder (ADHD) using the timeliness of stimulant prescription renewals over…
- Trial name
- NCT04189562
- Testing
- SMS Intervention
- Where
- United States
- Volunteers
- 300 people
- Sponsor
- Massachusetts General Hospital
Attention Deficit Hyperactivity Disorder
Investigating the Effects of the Temporal Adaptation Approach in Children With ADHD
This study investigates the impact of temporal adaptation interventions on children with Attention Deficit Hyperactivity Disorder (ADHD), focusing on activity self-efficacy, time perception, daily activity routines, and executive…
- Trial name
- NCT06770725
- Testing
- Temporal Adaptation Intervention, Conventional Occupational Therapy
- Where
- Turkey (Türkiye)
- Volunteers
- 60 people
- Sponsor
- Hacettepe University
Tourette's Syndrome, Attention Deficit Hyperactivity Disorder
Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD
In the present study, we examine the question "Will day-time aggression in children improve when their night-time sleep is treated with pharmacological intervention (i.e.
- Trial name
- NCT00152750
- Testing
- APO-clonidine
- Where
- Canada
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- University Health Network, Toronto
Mental and Behavioral Disorders, Withdrawal State
Effect of the Electronic Cigarette on Withdrawal Symptoms
Study rationale: Sensory/behavioural elements of smoking play a role in smoking behaviour and may have a potential to assist smoking cessation.
- Trial name
- ECIG24 (NCT01454362)
- Testing
- Nicotine
- Where
- United Kingdom
- Volunteers
- 51 people, healthy volunteers welcome
- Sponsor
- Queen Mary University of London
Alcoholism
Antabuse in Severe Alcoholism: an Open Controlled Study
Newly detoxified alcoholics (N=60) are randomised to either antabuse (disulfiram) treatment or the control group for a total of 6 months.All patients will receive cognitive behavioural treatment in groups.
- Trial name
- NCT00431262
- Testing
- antabuse (disulfiram)
- Where
- Denmark
- Volunteers
- 60 people
- Sponsor
- Psykiatrisk Center Gentofte
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.